The recommendation from ECDC follows reports of falsified rabies vaccines and anti-rabies serum circulating in the Philippines and is aimed at travellers who have received the vaccine or serum after possible exposure to rabies.
In 2019, World Youth Day (WYD) will take place between 22 and 27 January 2019 in Panama City, Panama with an expected half a million participants. During mass gathering events, the most common health risks are related to vaccine-preventable diseases, gastrointestinal illnesses and vector-borne diseases in favourable climate conditions.
The risks assessed in this document are of the introduction and further spread of monkeypox in the EU/EEA, infection with regards to different settings (e.g. healthcare, community, etc.) and transmission through SoHO.
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
This risk assessment is triggered by the increase in the number of yellow fever cases among EU travellers with exposure in South America since August 2016 and assesses the risk of contracting yellow fever for travellers to South America.
ECDC endorses the update in the WHO recommendations on preventative measures against Zika virus infection for returning travellers and is changing its recommendations accordingly.
This risk assessment focuses on the threat to the refugee population from communicable diseases and assesses the situation in Europe, associated with the current movements of refugees across the region and in the context of their living conditions and the approaching winter, access to shelter, sanitation and health services.
This rapid risk assessment analyses the unusual increase in the number of paratyphoid A infections in EU travellers returning from Cambodia since March 2013 with a possible persistent common source.
Since 1 January 2013 there have been 15 laboratory-confirmed cases of hepatitis A (HAV) infection reported in Germany, the Netherlands and Poland. All cases had travelled to the provinces of Trento and Bolzano in northern Italy during the exposure period.